Medicina Et Pharmacologia Experimentalis
On average, people can expect to lose between 10% and 20% of their body weight over the course of a year, depending on the specific medication and individual factors
As a class effect shared with GLP-1 receptor agonists, gallbladder problems including gallstones (cholelithiasis) and gallbladder inflammation (cholecystitis) have been observed with this type of medicine, and may be more likely with rapid weight loss
However, true plateaus do happen as well, and they are great opportunities to re-evaluate the plan
However, these patients often have severe comorbidities, altered nutritional status, and multiple medication interactions that complicate tirzepatide use
This integrated approach supports successful long-term outcomes by addressing both metabolic and musculoskeletal aspects of health simultaneously